Silo Pharma, Inc. (NASDAQ:SILO) Sees Large Decrease in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 101,900 shares, a drop of 21.2% from the October 15th total of 129,300 shares. Based on an average daily volume of 169,300 shares, the short-interest ratio is currently 0.6 days. Currently, 2.4% of the shares of the stock are sold short.

Silo Pharma Price Performance

Silo Pharma stock traded down $0.02 during trading hours on Friday, hitting $1.13. 221,630 shares of the stock were exchanged, compared to its average volume of 1,593,552. The business’s 50-day moving average is $1.11 and its two-hundred day moving average is $1.39. Silo Pharma has a 12 month low of $0.84 and a 12 month high of $4.50.

Silo Pharma (NASDAQ:SILO) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.31) EPS for the quarter. Silo Pharma had a negative return on equity of 63.95% and a negative net margin of 5,255.05%. The business had revenue of $0.02 million for the quarter.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.